Select Country
<br/>A broad range of imaging agents, procedures and devices that meet emerging medical challenges and facilitate clinical success <br/>One of the World's leading companies engaged in the development of new imaging solutions that address the evolving needs of patients <br/>Continuously invest in medical research and development, to provide innovative diagnostic products that match patients' needs <br/>A global partner with local resources. Everyday Bracco moves forward in all key diagnostic imaging modalities
1 2 3 4

Latest news

Bracco Diagnostics Inc. Creates First and Only U.S. FDA-Approved Multi-Dose Compliant Contrast Medium as Breakthrough Solution for Point-of-Care Use in the CT Suite

Bracco Diagnostic Inc. (BDI) today announced the availability of its innovative ISOVUE® (iopamidol injection) Imaging Bulk Package.

Press release


Bracco Diagnostics Inc. receives U.S. FDA Approval for new Ultrasound Contrast Agent

Lumason™ (sulfur hexafluoride lipid-type A microspheres) for injectable suspension, now available for use in adults with suboptimal echocardiograms.

Press release

Educational Events


Established to compare various clinical approaches for targeted diagnostic imaging.

Read more


Designed to help physicians stay abreast of the latest changes and applications in magnetic resonance.

Read more